Monocyte and macrophage biology: An overview

Seminars in Nephrology

Volumn 30, Issue 3, 2010, Pages 216-233

  Rees, Andrew J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemokine; Dendritic cell; Macrophage; Monocyte

Indexed keywords

ARTICLE; BONE MARROW; CELL HETEROGENEITY; CYTOLOGY; DENDRITIC CELL; HISTIOCYTE; HUMAN; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

ANIMALS; DENDRITIC CELLS; HUMANS; KIDNEY DISEASES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MONOCYTES;

EID: 77953901619     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.03.002     Document Type: Article

References (98)

1. Stuart L.M., Ezekowitz A.R. Phagocytosis and comparative innate immunity: learning on the fly. Nat Rev Immunol 2008, 8:131-141.
2. Rae F., Woods K., Sasmono T., Campanale N., Taylor D., Ovchinnikov D.A., et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol 2007, 308:232-246.
3. Lobov I.B., Rao S., Carroll T.J., Vallance J.E., Ito M., Ondr J.K., et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 2005, 437:417-421.
4. Machnik A., Neuhofer W., Jantsch J., Dahlmann A., Tammela T., Machura K., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009, 15:545-552.
5. Gordon S. The macrophage: past, present and future. Eur J Immunol 2007, 37:S9-S17.
6. Steinman R.M., Moberg C.L. Zanvil Alexander Cohn 1926-1993. J Exp Med 1994, 179:1-30.
7. van Furth R., Cohn Z.A., Hirsch J.G., Humphrey J.H., Specto W.G., Langevoort H.L. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ 1972, 46:845-852.
8. Mackaness G.B. Cellular resistance to infection. J Exp Med 1962, 116:381-406.
9. North R.J. Opinions: the concept of the activated macrophage. J Immunol 1978, 121:806-809.
10. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
11. Hume D.A., Ross I.L., Himes S.R., Sasmono R.T., Wells C.A., Ravasi T. The mononuclear phagocyte system revisited. J Leukoc Biol 2002, 72:621-627.
12. McKnight A.J., Gordon S. Membrane molecules as differentiation antigens of murine macrophages. Adv Immunol 1998, 68:271-314.
13. Hume D.A., Gordon S. Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. J Exp Med 1983, 157:1704-1709.
14. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007, 7:19-30.
15. Heath W.R., Carbone F.R. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009, 10:1237-1244.
16. Hume D.A. Macrophages as APC and the dendritic cell myth. J Immunol 2008, 181:5829-5835.
17. Sasmono R.T., Oceandy D., Pollard J.W., Tong W., Pavli P., Wainwright B.J., et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003, 101:1155-1163.
18. Krueger T., Benke D., Eitner F., Lang A., Wirtz M., Hamilton-Williams E.E., et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 2004, 15:613-621.
19. high monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009, 183:6733-6743.
20. Soos T.J., Sims T.N., Barisoni L., Lin K., Littman D.R., Dustin M.L., et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the kidney. Kidney Int 2006, 70:591-596.
21. Lukacs-Kornek V., Burgdorf S., Diehl L., Specht S., Kornek M., Kurts C. The kidney-renal lymph node-system contributes to cross-tolerance against innocuous circulating antigen. J Immunol 2008, 180:706-715.
22. Macconi D., Chiabrando C., Schiarea S., Aiello S., Cassis L., Gagliardini E., et al. Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides. J Am Soc Nephrol 2009, 20:123-130.
23. Ginhoux F., Liu K., Helft J., Bogunovic M., Greter M., Hashimoto D., et al. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 2009, 206:3115-3130.
24. Bogunovic M., Ginhoux F., Helft J., Shang L., Hashimoto L., Greter M., et al. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
25. Duffield J.S., Tipping P.G., Kipari T., Cailhier J.F., Clay S., Lang R., et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol 2005, 167;:1207-1219.
26. Scholz J., Lukacs-Kornek V., Engel D.R., Specht S., Kiss E., Eitner F., et al. Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis. J Am Soc Nephrol 2008, 19:527-537.
27. Woltman A.M., de Fijter J.W., Zuidwijk K., Vlug A.G., Bajema I.M., van der Kooij S.W., et al. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 2007, 71:1001-1008.
28. Segerer S., Hellerer F., Lindenmeyer M.T., Schmid H., Cohen C.D., Draganovici D., et al. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int 2008, 74:37-46.
29. Hart D.N., Fabre J.W. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 1981, 154:347-361.
30. Rosenbauer F., Tenen D.G. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007, 7:105-117.
31. Sarrazin S., Mossadegh-Keller N., Fukao T., Aziz A., Mourcin F., Vanhille L., et al. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 2009, 138:300-313.
32. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Ann Rev Immunol 2009, 27:669-692.
33. van Furth R., Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968, 128:415-435.
34. Serbina N.V., Pamer G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006, 7:311-317.
35. hi monocytosis an almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008, 117:1649-1657.
36. high monocytes from the bone marrow, but is dispensable for bladder infiltration in bacterial urinary tract infection. Immunology 2008, 181:5579-5586.
37. Karlmark K.R., Weiskirchen R., Zimmermann H.W., Gassler N., Ginhoux F., Weber C., et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009, 50:261-274.
38. Wang Y., Cui L., Gonsiorek W., Min S.-H., Anilkumar G., Rosenblum S., et al. CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J Inflamm (Lond) 2009, 6:32.
39. Li L., Huang L., Sung S.-S.J., Vergis A.L., Rosin D.L., Rose C.E., et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 2008, 74:1526-1537.
40. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007, 23:587-596.
41. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
42. Ting J., Pamer E.G. Dispensable but not irrelevant. Science 2009, 325:549-550.
43. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007, 81:584-592.
44. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115:e10-e19.
45. Ahuja V., Miller S.E., Howell D.N. Identification of two subpopulations of rat monocytes expressing disparate molecular forms and quantities of CD43. Cell Immunol 1995, 163:59-69.
46. Scriba A., Schneider M., Grau V., van der Meide P.H., Steiniger B. Rat monocytes up-regulate NKR-P1A and down-modulate CD4 and CD43 during activation in vivo: monocyte subpopulations in normal and IFN-gamma-treated rats. J Leukoc Biol 1997, 62:741-752.
47. Grau V., Scriba A., Stehling O., Steiniger B. Monocytes in the rat. Immunobiology 2000, 202;:94-103.
48. Yrlid U., Jenkins C.D., MacPherson G.G. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J Immunol 2006, 176:4155-4162.
49. Sanchez C., Domenech N., Vazquez J., Alonso F., Ezquerra A., Dominguez J. The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J Immunol 1999, 162:5230-5237.
50. Grage-Griebenow E., Flad H.D., Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001, 69:11-20.
51. Ziegler-Heitbrock H.W.L., Passlick B., Flieger D. The monoclonal anti-monocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 1988, 7:521-527.
52. Passlick B., Flieger D., Ziegler-Heitbrock H.W.L. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
53. Nockher W.A., Scherberich J.E. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998, 66:2782-2790.
54. Saionji K., Ohsaka A. Expansion of CD4+ CD16+ blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor. Acta Haematol 2001, 105:21-26.
55. Ancuta P., Moses A., Gabuzda D. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 2004, 209:11-20.
56. Nockher W.A., Wiemer J., Scherberich J.E. Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets. Clin Exp Immunol 2001, 123:49-55.
57. Sester U., Sester M., Heine G., Kaul H., Girndt M., Kohler H. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 2001, 16:1402-1408.
58. Fingerle-Rowson G., Angstwurm M., Andreesen R., Ziegler-Heitbrock H.W.L. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 1998, 112:501-506.
59. Dayyani F., Belge K.U., Frankenberger M., Mack M., Berki T., Ziegler-Heitbrock L. Mechanism of glucocorticoid-induced depletion of human CD14+ CD16+ monocytes. J Leukoc Biol 2003, 74:33-39.
60. Steppich B., Dayyani F., Gruber R., Lorenz R., Mack M., Ziegler-Heitbrock H.W. Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am J Physiol Cell Physiol 2000, 279:C578-C586.
61. Kittner J.M., Jacobs R., Pawlak C.R., Heijnen C.J., Schedlowski M., Schmidt R.E. Adrenaline-induced immunological changes are altered in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002, 41:1031-1039.
62. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000, 20:4106-4114.
63. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
64. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172:4410-4417.
65. Varol C., Landsman L., Fogg D.K., Greenshtein L., Gildor B., Margalit R., et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 2007, 204:171-180.
66. Randolph G.J., Sanchez-Schmitz G., Liebman R.M., Schäkel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002, 196:517-527.
67. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
68. Minto A.W., Erwig L.P., Rees A.J. Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis. Am J Pathol 2003, 163:2033-2041.
69. Lambrecht B.N., Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009, 31:412-424.
70. Ginhoux F., Tacke F., Angeli V., Bogunovic M., Loubeau M., Dai X.M., et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006, 7:265-273.
71. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007, 71:619-628.
72. Li L., Huang L., Sung S.-S.J., Vergis A.L., Rosin D.L., Rose C.E., et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 2008, 74:1526-1537.
73. Henderson N.C., Mackinnon A.C., Farnworth S.L., Kipari T., Haslett C., Iredale J.P., et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 2008, 172:288-298.
74. Heymann F., Meyer-Schwesinger C., Hamilton-Williams E.E., Hammerich L., Panzer U., Kaden S., et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest 2009, 119:1286-1297.
75. Qi F., Adair A., Ferenbach D., Vass D.G., Mylonas K.J., Kipari T., et al. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 2008, 86:1267-1274.
76. Imhof B.A., Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004, 4:432-444.
77. Kamei M., Carman C.V. New observations on the trafficking and diapedesis of monocytes. Curr Opin Hematol 2009, 17:43-52.
78. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
79. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
80. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
81. Martinez F.O. The transcriptome of human monocyte subsets begins to emerge. J Biol 2009, 8:99.
82. Walmsley S.R., McGovern N.N., Whyte M.K.B., Chilvers E.R. The HIF/VHL pathway. From oxygen sensing to innate immunity. Am J Respir Cell Mol Biol 2008, 38:251-255.
83. Liu Y., Stewart K.N., Bishop E., Marek C.J., Kluth D.C., Rees A.J., et al. Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J Immunol 2008, 180:6270-6278.
84. Schroder K., Sweet M.J., Hume D.A. Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology 2006, 211:511-524.
85. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002, 2:965-975.
86. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8:279-289.
87. Bystrom J., Evans I., Newson J., Stables M., Toor I., van Rooijen N., et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008, 112:4117-4127.
88. Erwig L.P., Kluth D.C., Walsh G.M., Rees A.J. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J Immunol 1998, 161:1983-1988.
89. Wilson H.M., Chettibi S., Jobin C., Walbaum D., Rees A.J., Kluth D.C. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 2005, 167:27-37.
90. O'Shea J.J., Murray P.J. Cytokine signalling modules in inflammatory responses. Immunity 2008, 28:477-487.
91. Murray P.J. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007, 178:2623-2629.
92. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
93. Weichhart T., Costantino G., Poglitsch M., Rosner M., Zeyda M., Stuhlmeier K.M., et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 2008, 29:565-577.
94. Weichhart T., Säemann M.D. The multiple facets of mTOR in immunity. Trends Immunol 2009, 30:218-226.
95. Rauh M.J., Sly L.M., Kalesnikoff J., Hughes M.R., Cao L.-P., Lam V., et al. The role of SHIP1 in macrophage programming and activation. Biochem Soc Trans 2004, 23:785-788.
96. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005, 6:777-784.
97. Ravasi T., Wells C.A., Hume D.A. Systems biology of transcription control in macrophages. Bioessays 2007, 29:1215-1226.
98. Zak D.E., Aderem A. Systems biology of innate immunity. Immunol Rev 2009, 227:264-282.